Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Center | 9 | 2019 | 54 | 2.350 |
Why?
|
| Neuronal Plasticity | 7 | 2021 | 194 | 2.100 |
Why?
|
| Respiration | 9 | 2024 | 267 | 1.860 |
Why?
|
| Respiratory Physiological Phenomena | 5 | 2020 | 48 | 1.790 |
Why?
|
| Neurons | 14 | 2024 | 1588 | 1.700 |
Why?
|
| Brain Stem | 6 | 2024 | 167 | 1.670 |
Why?
|
| Hypoxia | 7 | 2020 | 656 | 1.450 |
Why?
|
| CA1 Region, Hippocampal | 3 | 2021 | 24 | 1.440 |
Why?
|
| Hypoxia, Brain | 2 | 2021 | 43 | 1.360 |
Why?
|
| Respiratory Mechanics | 8 | 2019 | 102 | 1.260 |
Why?
|
| Animals, Newborn | 7 | 2024 | 524 | 1.060 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2024 | 7 | 0.930 |
Why?
|
| Neonatal Sepsis | 1 | 2024 | 5 | 0.930 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2024 | 35 | 0.910 |
Why?
|
| Neurogenesis | 4 | 2020 | 77 | 0.890 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 91 | 0.880 |
Why?
|
| Arousal | 3 | 2013 | 170 | 0.860 |
Why?
|
| Gasotransmitters | 1 | 2023 | 14 | 0.850 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2021 | 107 | 0.850 |
Why?
|
| Respiratory Insufficiency | 2 | 2019 | 161 | 0.840 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 294 | 0.820 |
Why?
|
| Respiratory System | 2 | 2020 | 116 | 0.800 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2023 | 217 | 0.770 |
Why?
|
| Hyperoxia | 3 | 2010 | 35 | 0.760 |
Why?
|
| Organoids | 1 | 2021 | 63 | 0.750 |
Why?
|
| Dentate Gyrus | 2 | 2018 | 32 | 0.740 |
Why?
|
| Nerve Net | 6 | 2021 | 374 | 0.740 |
Why?
|
| Mice | 22 | 2024 | 11832 | 0.740 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 87 | 0.730 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2021 | 121 | 0.730 |
Why?
|
| Biological Clocks | 3 | 2011 | 74 | 0.710 |
Why?
|
| Spatial Memory | 1 | 2020 | 27 | 0.700 |
Why?
|
| Animals | 31 | 2024 | 27481 | 0.700 |
Why?
|
| Oxidative Stress | 2 | 2021 | 457 | 0.690 |
Why?
|
| In Vitro Techniques | 8 | 2021 | 996 | 0.640 |
Why?
|
| Periodicity | 4 | 2013 | 119 | 0.590 |
Why?
|
| Oxygen | 4 | 2010 | 744 | 0.570 |
Why?
|
| Medulla Oblongata | 3 | 2023 | 93 | 0.550 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 201 | 0.530 |
Why?
|
| Flufenamic Acid | 2 | 2014 | 13 | 0.490 |
Why?
|
| Riluzole | 2 | 2014 | 15 | 0.490 |
Why?
|
| Lip | 1 | 2014 | 16 | 0.470 |
Why?
|
| Hyperbaric Oxygenation | 2 | 2010 | 13 | 0.450 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 73 | 0.440 |
Why?
|
| Hippocampus | 2 | 2020 | 449 | 0.430 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2013 | 36 | 0.430 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2013 | 22 | 0.430 |
Why?
|
| Brain | 2 | 2021 | 2300 | 0.420 |
Why?
|
| Sudden Infant Death | 1 | 2013 | 27 | 0.420 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 175 | 0.420 |
Why?
|
| Autonomic Nervous System | 1 | 2013 | 65 | 0.410 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2011 | 9 | 0.380 |
Why?
|
| Oxidants | 1 | 2011 | 86 | 0.380 |
Why?
|
| Infant, Premature | 1 | 2013 | 298 | 0.370 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 158 | 0.370 |
Why?
|
| Sex Characteristics | 1 | 2013 | 327 | 0.360 |
Why?
|
| Patch-Clamp Techniques | 3 | 2021 | 396 | 0.360 |
Why?
|
| Motor Neurons | 2 | 2023 | 176 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 3240 | 0.330 |
Why?
|
| Neural Pathways | 3 | 2021 | 319 | 0.310 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2018 | 88 | 0.270 |
Why?
|
| Microglia | 2 | 2024 | 108 | 0.260 |
Why?
|
| Neural Stem Cells | 2 | 2018 | 58 | 0.260 |
Why?
|
| Hypoglossal Nerve | 2 | 2023 | 27 | 0.240 |
Why?
|
| Lipopeptides | 1 | 2024 | 17 | 0.230 |
Why?
|
| Astrocytes | 1 | 2024 | 142 | 0.220 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2024 | 58 | 0.220 |
Why?
|
| Dynamins | 1 | 2024 | 50 | 0.220 |
Why?
|
| Male | 11 | 2024 | 42488 | 0.210 |
Why?
|
| Ligands | 1 | 2024 | 447 | 0.210 |
Why?
|
| Female | 10 | 2024 | 46401 | 0.200 |
Why?
|
| Electrophysiology | 2 | 2021 | 403 | 0.200 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 490 | 0.190 |
Why?
|
| Wakefulness | 2 | 2019 | 135 | 0.190 |
Why?
|
| GABA Antagonists | 2 | 2011 | 25 | 0.190 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 111 | 0.180 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 278 | 0.180 |
Why?
|
| Hypoventilation | 1 | 2020 | 6 | 0.180 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2011 | 80 | 0.180 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 194 | 0.180 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 205 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 375 | 0.180 |
Why?
|
| Sleep Apnea, Central | 1 | 2020 | 14 | 0.180 |
Why?
|
| Apnea | 1 | 2020 | 31 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 118 | 0.170 |
Why?
|
| Pressure | 2 | 2010 | 165 | 0.170 |
Why?
|
| Reactive Nitrogen Species | 1 | 2018 | 8 | 0.160 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 21 | 0.160 |
Why?
|
| Morphine | 1 | 2019 | 130 | 0.160 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 59 | 0.160 |
Why?
|
| Neuroglia | 1 | 2018 | 105 | 0.160 |
Why?
|
| Fibroblasts | 1 | 2021 | 759 | 0.160 |
Why?
|
| Long-Term Potentiation | 1 | 2018 | 48 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 222 | 0.150 |
Why?
|
| Neuropeptides | 1 | 2018 | 115 | 0.150 |
Why?
|
| Homeodomain Proteins | 2 | 2020 | 559 | 0.150 |
Why?
|
| Inflammation | 1 | 2024 | 975 | 0.150 |
Why?
|
| Machine Learning | 1 | 2020 | 263 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2021 | 277 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 184 | 0.150 |
Why?
|
| Homeostasis | 3 | 2024 | 417 | 0.150 |
Why?
|
| Central Pattern Generators | 1 | 2017 | 4 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 1237 | 0.140 |
Why?
|
| Cell Lineage | 1 | 2018 | 292 | 0.140 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2884 | 0.130 |
Why?
|
| Time Factors | 4 | 2016 | 5337 | 0.130 |
Why?
|
| Infant, Newborn | 1 | 2021 | 2488 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 451 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2017 | 602 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2014 | 70 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2016 | 85 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 743 | 0.120 |
Why?
|
| Synapses | 2 | 2016 | 280 | 0.120 |
Why?
|
| Models, Neurological | 1 | 2017 | 411 | 0.110 |
Why?
|
| Rats | 2 | 2010 | 4041 | 0.110 |
Why?
|
| Norepinephrine | 1 | 2014 | 172 | 0.110 |
Why?
|
| KATP Channels | 1 | 2013 | 19 | 0.110 |
Why?
|
| Calcium Channels, N-Type | 1 | 2013 | 17 | 0.110 |
Why?
|
| Potassium Channel Blockers | 1 | 2013 | 64 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1668 | 0.100 |
Why?
|
| Evoked Potentials | 1 | 2013 | 191 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2020 | 1663 | 0.100 |
Why?
|
| Integrases | 1 | 2012 | 63 | 0.100 |
Why?
|
| Picrotoxin | 1 | 2011 | 5 | 0.100 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2011 | 15 | 0.100 |
Why?
|
| Deferoxamine | 1 | 2011 | 18 | 0.100 |
Why?
|
| Ferrous Compounds | 1 | 2011 | 17 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 125 | 0.100 |
Why?
|
| Malondialdehyde | 1 | 2011 | 26 | 0.100 |
Why?
|
| Siderophores | 1 | 2011 | 22 | 0.100 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 44 | 0.100 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 2011 | 4 | 0.100 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2011 | 4 | 0.100 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2011 | 14 | 0.100 |
Why?
|
| Invertebrates | 1 | 2011 | 33 | 0.100 |
Why?
|
| Animals, Outbred Strains | 1 | 2011 | 17 | 0.100 |
Why?
|
| Biophysics | 1 | 2011 | 153 | 0.090 |
Why?
|
| Humans | 7 | 2021 | 89613 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2011 | 244 | 0.090 |
Why?
|
| Light | 1 | 2012 | 292 | 0.090 |
Why?
|
| Polarography | 1 | 2010 | 8 | 0.090 |
Why?
|
| Ion-Selective Electrodes | 1 | 2010 | 4 | 0.090 |
Why?
|
| Vertebrates | 1 | 2011 | 105 | 0.090 |
Why?
|
| Neural Inhibition | 3 | 2017 | 97 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2011 | 365 | 0.090 |
Why?
|
| Action Potentials | 2 | 2012 | 600 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 245 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2010 | 154 | 0.080 |
Why?
|
| Piperazines | 1 | 2011 | 282 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 663 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2011 | 378 | 0.080 |
Why?
|
| Aging | 1 | 2013 | 724 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1928 | 0.070 |
Why?
|
| Infant | 1 | 2013 | 3176 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2007 | 130 | 0.070 |
Why?
|
| Risk Factors | 2 | 2013 | 5517 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2007 | 182 | 0.060 |
Why?
|
| Mammals | 1 | 2007 | 237 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2024 | 25 | 0.060 |
Why?
|
| Noble Gases | 1 | 2003 | 1 | 0.060 |
Why?
|
| Mitochondria, Heart | 1 | 2024 | 50 | 0.060 |
Why?
|
| Hypercapnia | 1 | 2003 | 44 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2384 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 135 | 0.050 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 56 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 1877 | 0.050 |
Why?
|
| Adult | 1 | 2021 | 26704 | 0.050 |
Why?
|
| Synaptic Transmission | 2 | 2014 | 228 | 0.050 |
Why?
|
| Plethysmography | 1 | 2020 | 18 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 314 | 0.050 |
Why?
|
| Tidal Volume | 1 | 2020 | 54 | 0.050 |
Why?
|
| Calcium | 1 | 2024 | 1178 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1576 | 0.040 |
Why?
|
| Cholinergic Neurons | 1 | 2016 | 9 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 79 | 0.030 |
Why?
|
| Cadmium | 1 | 2014 | 28 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 2014 | 27 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2014 | 121 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2449 | 0.030 |
Why?
|
| Phrenic Nerve | 1 | 2013 | 42 | 0.030 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2013 | 8 | 0.030 |
Why?
|
| Calcium Channels, P-Type | 1 | 2013 | 10 | 0.030 |
Why?
|
| Nestin | 1 | 2013 | 18 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 58 | 0.030 |
Why?
|
| Intermediate Filament Proteins | 1 | 2013 | 35 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2013 | 67 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 56 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 34 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 22 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 45 | 0.030 |
Why?
|
| Polysomnography | 1 | 2013 | 151 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 223 | 0.030 |
Why?
|
| Halorhodopsins | 1 | 2012 | 5 | 0.030 |
Why?
|
| Channelrhodopsins | 1 | 2012 | 7 | 0.030 |
Why?
|
| Archaeal Proteins | 1 | 2012 | 18 | 0.030 |
Why?
|
| Optics and Photonics | 1 | 2012 | 27 | 0.030 |
Why?
|
| Electroporation | 1 | 2012 | 57 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 168 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 309 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 65 | 0.020 |
Why?
|
| Synaptic Potentials | 1 | 2011 | 15 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 144 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 394 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 289 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 899 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 511 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 589 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 2014 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 786 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1529 | 0.020 |
Why?
|
| Inert Gas Narcosis | 1 | 2003 | 1 | 0.010 |
Why?
|
| Air Pressure | 1 | 2003 | 7 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 2003 | 52 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2003 | 153 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 4160 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 1903 | 0.010 |
Why?
|